Production (Stage)
PMV Pharmaceuticals, Inc.
PMVP
$0.97
$0.022.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -60.88M | -58.71M | -51.47M | -48.88M | -65.10M |
| Total Depreciation and Amortization | 819.00K | 1.14M | 1.46M | 1.45M | 1.45M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.65M | 7.88M | 4.02M | 4.58M | 5.39M |
| Change in Net Operating Assets | -953.00K | -1.59M | -729.00K | -2.68M | 1.44M |
| Cash from Operations | -53.36M | -51.28M | -46.71M | -45.53M | -56.83M |
| Capital Expenditure | -65.00K | -655.00K | -796.00K | -839.00K | -1.40M |
| Sale of Property, Plant, and Equipment | 251.00K | 251.00K | 29.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 55.71M | 53.76M | 43.79M | -6.90M | -72.62M |
| Cash from Investing | 55.90M | 53.35M | 43.02M | -7.74M | -74.02M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 323.00K | 313.00K | 429.00K | 33.58M | 35.57M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 323.00K | 313.00K | 429.00K | 33.58M | 35.57M |
| Foreign Exchange rate Adjustments | 6.00K | -35.00K | 10.00K | 6.00K | 0.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.87M | 2.35M | -3.25M | -19.68M | -95.29M |